bisoprolol has been researched along with Atherogenesis in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, H | 1 |
| Du, RZ | 1 |
| Qiu, JP | 1 |
| Tang, YQ | 1 |
| Chen, SC | 1 |
1 other study available for bisoprolol and Atherogenesis
| Article | Year |
|---|---|
Bisoprolol reverses epinephrine-mediated inhibition of cell emigration through increases in the expression of β-arrestin 2 and CCR7 and PI3K phosphorylation, in dendritic cells loaded with cholesterol.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Androstadienes; Arrestins; Atheros | 2013 |